Annual Alpha-1 Patient Meeting 2014
Thursday, October 2nd 2014 09:23
article thumbnailThe Alpha One Foundation is delighted to announce the Annual Alpha-1 Conference will take place on: Friday 24th October 2014, commencing at 9.30 am in Marino Institute of Education, Griffith Avenue, Dublin 9. We would like to invite all Alpha-1 patients and their families to attend. We would especially like to welcome...
National Lung Health Awareness Week 22 - 29 Sept
Tuesday, September 16th 2014 15:04
article thumbnailA recent survey has revealed that one in every two people nationwide has experienced lung disease, either personally or through a member of their family. Yet only 18% have had their lungs tested over the past five years and significant numbers of people were unable to identify the important symptoms of lung disease when...
Alpha-1 Global Website Launch
Tuesday, September 9th 2014 16:04
article thumbnailThe new Alpha-1 Global website was launched last month. The site provides a platform for Alpha-1 patients to communicate and to collaborate; to provide a central network for exchange of news, information and ideas on improving Alpha-1 awareness, detection and access to care around the world. The main aims of Alpha-1...
Annual Alpha-1 Conference 2014
Thursday, August 14th 2014 14:43
article thumbnailThe annual Alpha-1 conference will take place this year on Friday, October 24th in the Marino Institute of Education in Dublin. We are delighted to confirm that Mr. John Walsh, CEO of the US Alpha-1 Foundation will be our very special guest speaker. John is an Irish-American with Alpha-1 who co-founded the US Alpha-1...
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test. 
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, along with cystic fibrosis, is the commonest genetic lung disease in Ireland. It severely affects more than 12,000 people, with another 170,000 carriers also at risk of lung and liver disease. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
Go to top